Mirvie

About

Mirvie is a healthcare company based in South San Francisco, California, dedicated to improving pregnancy health through innovative, non-invasive testing solutions. Founded in 2018, Mirvie focuses on predicting and preventing complications during pregnancy by utilizing RNA analysis and machine learning technologies. The company's mission is inspired by a personal experience of one of its founders, emphasizing the importance of early detection and intervention. The flagship product, the Mirvie RNA platform, employs a simple blood test to analyze RNA messages from the baby, placenta, and mother. This platform enables early detection of potential complications, such as preeclampsia, allowing for proactive and personalized pregnancy care. Mirvie has received CLIA certification, demonstrating its commitment to high standards in clinical laboratory testing. With significant backing from top-tier investors and ongoing clinical research, Mirvie aims to transform the landscape of women's health and enhance outcomes for expecting parents and healthcare providers.